Please login to the form below
Healthcare terms - I
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare terms - I
- (Chartered) Institute of Public Relations (IPR)
- i-Coach
- In-Company training
- In-house
- In-house newspaper/magazine
- Inclusion/exclusion criteria
- Incremental cost-effectiveness ratio (ICER)
- Indication
- Inducements
- Industrial marketing
- Infant
- Infiltration marketing
- Informed consent
- Informed consent document
- Institute of Practitioners in Advertising (IPA)
- Institutional review board (IRB) - pharmacoeconomics
- Intent to treat
- Internal analysis
- Internal communications
- Internal Customers
- Internal marketing
- Internal relations officer (IRO)
- International Clinical Trial Registry Platform (ICTRP)
- International Committee of Medical Journal Editors (ICMJE)
- International marketing
- International nonproprietary name (INN)
- International Public Relations Association (IPRA)
- Interventions - clinical
- Intrapreneur
- Intrapreneurship
- Investigational new drug (IND)
Featured jobs
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Consultant
-
competitive salary
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Director or Senior Account Director
-
Salary TBC
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
-
Vice President
-
Competitive Salary Offered
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
Subscribe to our email news alerts
- Moving annual total (MAT)
- NantKwest rockets on promising pancreatic cancer data
- Latecomer Lilly preps its IL-23 drug for Crohn’s disease
- NantKwest rockets on promising pancreatic cancer data
- Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer
- Novo Nordisk gets MACE prevention claim for Ozempic in US
PMHub
Real Science Communications
Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...
Quick links
Infographics
